Xcout Intel
Gritstone bio, Inc.
Gritstone bio, Inc. is a clinical-stage biotechnology company headquartered in Emeryville, California. The firm engages in developing next-generation cancer immunotherapies and vaccines to fight various forms of cancer and infectious diseases.
Subscribe to see Gritstone bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Gritstone bio, Inc. at a glance
Gritstone bio, Inc. is a healthcare company headquartered in United States. It has raised at least $295M across the 4 funding rounds on record. Its most recent funding round raised $45M in October 2022. Xcout tracks 2 named people at Gritstone bio, Inc., including Wayne Robinson (CEO).
Gritstone bio, Inc. leadership
- Wayne RobinsonCEO
- Rachel MillerVP of Operations
Gritstone bio, Inc. funding rounds
At least $295M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $45M | — | |
| SEC Form D filing | $55M | — | |
| Series B | $93M | — | |
| Series A | $102M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Gritstone bio, Inc. competitors
A few of Gritstone bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Enara Bio, Ltd. is a UK biotechnology company that discovers cancer targets, including tumor-specific antigens, using immunopeptidomics and machine-learning technologies. It works with biopharmaceutical companies to support development of cancer vaccines and other targeted immunotherapies.
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
GENEOS Therapeutics, Inc. is a biotechnology company focused on developing exquisitely personalized, EPIC-based cancer immunotherapies. The company is headquartered in Philadelphia, Pennsylvania, United States.
GEn1E Lifesciences Inc. is a clinical-stage, Phase 2 biotechnology research company based in Palo Alto, California, focused on accelerating novel precision therapies.
ExpreS2ion Biotech Holding is a clinical-stage biotechnology company that develops innovative immunotherapies and vaccines to treat cancer and prevent infectious diseases. Utilizing its proprietary ExpreS2 protein expression system and a virus-like particle delivery platform, the company creates candidates such as its lead HER2 cancer immunotherapy, ES2B-C001.
Get Gritstone bio, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Gritstone bio, Inc. in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access